Filing Details

Accession Number:
0001104659-23-036172
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-03-23 20:28:29
Reporting Period:
2023-03-23
Accepted Time:
2023-03-23 20:28:29
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1326190 Altimmune Inc. ALT Pharmaceutical Preparations (2834) 202726770
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1787762 Scott Matthew Harris C/O Altimmune, Inc.,
910 Clopper Road, Suite 201S
Gaithersburg MD 20878
Chief Medical Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $0.0001 Acquisiton 2023-03-23 10,000 $4.22 33,311 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct